Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
12/08/202107:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
12/08/202107:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
09/08/202122:40PR Newswire (US)Oramed to Present at Canaccord Genuity's 41st Annual Growth ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
07/08/202106:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
05/08/202121:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
05/08/202120:40PR Newswire (US)Oravax to Present Keynote Talk on Oral COVID-19 Vaccine at the Arena International Vaccines Virtual Conference 2021NASDAQ:ORMPOramed Pharmaceuticals Inc
05/08/202106:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ORMPOramed Pharmaceuticals Inc
03/08/202106:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
29/07/202122:25PR Newswire (US)Oramed Pharmaceuticals Appoints Chief Commercial OfficerNASDAQ:ORMPOramed Pharmaceuticals Inc
29/07/202106:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ORMPOramed Pharmaceuticals Inc
27/07/202120:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ORMPOramed Pharmaceuticals Inc
21/07/202122:25PR Newswire (US)Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical TrialNASDAQ:ORMPOramed Pharmaceuticals Inc
17/07/202106:16Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ORMPOramed Pharmaceuticals Inc
16/07/202107:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ORMPOramed Pharmaceuticals Inc
16/07/202106:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
15/07/202106:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
09/07/202106:30Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ORMPOramed Pharmaceuticals Inc
22/06/202122:40PR Newswire (US)Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® IndexesNASDAQ:ORMPOramed Pharmaceuticals Inc
17/06/202106:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ORMPOramed Pharmaceuticals Inc
16/06/202123:37Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)NASDAQ:ORMPOramed Pharmaceuticals Inc
08/06/202122:10PR Newswire (US)Oramed Reaches 50% Enrollment in Phase 3 Oral Insulin StudyNASDAQ:ORMPOramed Pharmaceuticals Inc
26/05/202106:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
25/05/202122:40PR Newswire (US)Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 VaccineNASDAQ:ORMPOramed Pharmaceuticals Inc
11/05/202106:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
21/04/202121:25PR Newswire (US)Oramed Pharmaceuticals and Oravax Medical to be Featured in Alliance Global Partners' Grand Rounds: A Webinar in Biotech and ...NASDAQ:ORMPOramed Pharmaceuticals Inc
14/04/202106:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
23/03/202123:51PR Newswire (US)Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA's Approved Dual Concurrent ProtocolNASDAQ:ORMPOramed Pharmaceuticals Inc
23/03/202122:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
22/03/202118:06Business WirePremas Biotech et Oramed annoncent un vaccin candidat oral contre la COVID-19 qui produit des anticorps après une seule doseNASDAQ:ORMPOramed Pharmaceuticals Inc
20/03/202101:30Business WirePremas Biotech and Oramed Announce Oral COVID-19 Vaccine Candidate That Produces Antibodies After a Single DoseNASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP

Your Recent History

Delayed Upgrade Clock